Early results of combined Her-2/neu (HER2) immunotherapy using a HER2 peptide vaccine with concurrent trastuzumab for metastatic breast cancer.

被引：0
|
作者：
Webster, D.
Waisman, J.
MacLeod, B.
dela Rosa, C.
Higgins, D.
Fintak, P.
Childs, J.
Slota, M.
Salazar, L.
Disis, M.
机构：
[1] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [31] Correlation between HER2 amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2 positive breast cancer.
    Antolin, Silvia
    Garcia-Caballero, Lucia
    Reboredo, Cristina
    Molina Diaz, Aurea
    Mosquera, Joaquin
    Vazquez-Boquete, Angel
    Gallego, Rosalia
    Paz Santiago, Maria
    Concha, Angel
    Eva Perez, Maria
    Calvo, Lourdes
    Garcia-Caballero, Tomas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Comparison of serum HER2/neu with immunohistochemical HER2/neu expression for the prediction of biochemical progression in metastatic prostate cancer
    Tambo, Mitsuhiro
    Higashihara, Eiji
    Terado, Yuichi
    Nutahara, Kikuo
    Okegawa, Takatsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (04) : 369 - 374
  • [33] Is it rational to detect HER-2/neu gene amplification in breast cancer patients without expression of HER2 protein? Results of HER retest project
    Ryska, A.
    VIRCHOWS ARCHIV, 2011, 459 : S2 - S3
  • [34] HER-2/neu determination in blood plasma of patients with HER2/neu overexpressing metastasized breast cancer:: A longitudinal study
    Hoopmann, M
    Neumann, R
    Tanasale, T
    Schöndorf, T
    ANTICANCER RESEARCH, 2003, 23 (2A) : 1031 - 1034
  • [35] Prognostic role of plasma HER2 gene copy number in patients with HER2 positive metastatic breast cancer.
    Ran, Ran
    Huang, Wenfa
    Lin, Shao
    Niu, Yunyun
    Rugo, Hope S.
    Kong, Weiyao
    Bo, Shiping
    Lu, Sijia
    Li, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] HER2/neu in the management of invasive breast cancer
    Meric, F
    Hung, MC
    Hortobagyi, GN
    Hunt, KK
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (04) : 488 - 501
  • [37] Study of oncogen HER2/neu in breast cancer
    San Miguel, Angel
    Martin, Lourdes
    San Miguel-Hernandez, Rafael
    Gonzalez Blanco, Ignacio
    Martin-Gil, Francisco J.
    GINECOLOGIA Y OBSTETRICIA CLINICA, 2008, 9 (02): : 83 - 91
  • [38] Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer
    Kong, Sun-Young
    Nam, Byung-Ho
    Lee, Keun Seok
    Kwon, Youngmee
    Lee, Eun Sook
    Seong, Moon-Woo
    Lee, Do Hoon
    Ro, Jungsil
    CLINICAL CHEMISTRY, 2006, 52 (08) : 1510 - 1515
  • [39] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [40] HER2:: The Neu prognostic marker for breast cancer
    Tsongalis, GJ
    Ricci, A
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2001, 38 (02) : 167 - 182
12345